Login to Your Account

Fed Cancer Funding Good, but More Needed, Says BIO

By Donna Young

Friday, February 27, 2009
WASHINGTON - While the more than $6 billion increase in President Obama's fiscal year 2010 budget proposal for cancer research is a positive step in finding new cures, that progress could be for naught if Congress fails to give biotech companies - which are involved in developing and advancing more than 250 investigational cancer products - tax breaks and other needed help to survive the economic downturn, said Jim Greenwood, CEO of the Biotechnology Industry Organization (BIO). (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription